1. Aberrant expression of HIF3A in plasma of patients with non‐small cell lung cancer and its clinical significance
- Author
-
Pingping Gong, Yingying Chen, Na Yuan, and Liang Wei
- Subjects
Male ,non‐small cell lung cancer ,Microbiology (medical) ,Lung Neoplasms ,Clinical Biochemistry ,Alpha (ethology) ,Adenocarcinoma of Lung ,Sensitivity and Specificity ,Carcinoma, Non-Small-Cell Lung ,Biomarkers, Tumor ,medicine ,Humans ,Immunology and Allergy ,Clinical significance ,RNA, Messenger ,Lung cancer ,Research Articles ,plasma ,Aged ,Lung ,hypoxia ,business.industry ,Biochemistry (medical) ,Public Health, Environmental and Occupational Health ,Area under the curve ,Hematology ,Middle Aged ,Hypoxia (medical) ,medicine.disease ,HIF3A ,mRNA gene ,Gene Expression Regulation, Neoplastic ,Repressor Proteins ,Medical Laboratory Technology ,medicine.anatomical_structure ,ROC Curve ,Case-Control Studies ,Lymphatic Metastasis ,Cancer research ,Tumor Hypoxia ,Adenocarcinoma ,Female ,medicine.symptom ,Apoptosis Regulatory Proteins ,business ,Research Article - Abstract
Background Hypoxia‐inducible factors (HIFs) have been evaluated in various cancers and diseases. However, the specific role of hypoxia‐inducible factor 3 alpha (HIF3A) in non‐small cell lung cancer (NSCLC) remains controversial. Materials and Methods We investigated HIF3A mRNA expression in the plasma and tumor tissues of patients with NSCLC and explored its clinical significance. Plasma samples from 103 cases of lung adenocarcinoma (LUAD) and 96 cases of lung squamous cell carcinoma (LUSC), and tumor‐adjacent normal tissues from 58 LUAD and 62 LUSC cases were retrospectively evaluated at the No.8 People's Hospital of Qing Dao. HIF3A expression was explored using RT‐qPCR. The clinical significance of HIF3A was evaluated in the plasma and tumor tissues using the receiver operating curve (ROC) and the area under the curve (AUC). Results Hypoxia‐inducible factor 3 alpha expression was notably downregulated in the plasma or tumor tissues of patients with LUAD and LUSC, compared with the healthy control group or adjacent normal tissues. Furthermore, HIF3A expression had a significant positive correlation in the plasma and tumor tissues of LUAD and LUSC patients. Meanwhile, the ROC‐AUCs achieved a significantly higher range, from 0.84 to 0.93, with the plasma or tumor tissues of NSCLC patients. Thus, HIF3A expression was not only correlated with plasma and tumor tissues, but also showed potential significance in NSCLC. Conclusion Hypoxia‐inducible factor 3 alpha is aberrantly detectable in NSCLC patients in the plasma and tumor tissues. HIF3A may be involved in hypoxic responses during the development and occurrence of NSCLC., Bioinformatics‐based differential signature scores analysis in box plots by using GEPIA2 tool. The signature score is calculated by the mean value of log2 (TPM +1) of each gene in HIF3A signature gene set. The red box indicates the tumor samples while the gray one represents the normal adjacent tissues. The HIF3A signature score level in NSCLC is significantly lower than normal tissues.
- Published
- 2021